Post-earnings recap
Reported
Tue, Oct 28, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Techne Corp's earnings report showed a slight miss on EPS, which contributed to a 3.63% decline in stock price. The lack of revenue data and guidance may have added to investor uncertainty. Overall, the market reaction suggests cautious sentiment among investors regarding the company's near-term outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.85 | N/A | -1.85% |
| Revenue | N/A | N/A | N/A |
Overall, management maintained a neutral stance on the company's performance. They highlighted ongoing market challenges but did not offer specific future guidance.
Management did not provide specific revenue guidance for the upcoming quarters.
The company acknowledged challenges in the current market environment.